237 related articles for article (PubMed ID: 37537844)
1. Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma.
Rosenberg MI; Greenstein E; Buchkovich M; Peres A; Santoni-Rugiu E; Yang L; Mikl M; Vaksman Z; Gibbs DL; Reshef D; Salovin A; Irwin MS; Naranjo A; Ulitsky I; de Alarcon PA; Matthay KK; Weigman V; Yaari G; Panzer JA; Friedman N; Maris JM
Cell Rep; 2023 Aug; 42(8):112879. PubMed ID: 37537844
[TBL] [Abstract][Full Text] [Related]
2. Surgical considerations for neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: a series of 14 patients from a single institution.
Johnston WR; Hwang R; Mattei P
Pediatr Surg Int; 2022 Feb; 38(2):249-255. PubMed ID: 34549330
[TBL] [Abstract][Full Text] [Related]
3. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
Delap S; Shah N; Kuns O; Franklin B; Skeens MA
Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
[TBL] [Abstract][Full Text] [Related]
4. Benign paraspinal ganglioneuroma with paraneoplastic opsoclonus myoclonus syndrome.
Prabaharan H; Chandrasekaran S; Shetty N; Nayak K P
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38417946
[TBL] [Abstract][Full Text] [Related]
5. Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.
Patel A; Fischer C; Lin YC; Basu EM; Kushner BH; De Braganca K; Khakoo Y
Pediatr Blood Cancer; 2020 Aug; 67(8):e28319. PubMed ID: 32543116
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome: Role of Chemotherapy in the Management: Experience From a Tertiary Care Center in a Resource-limited Setting.
Anand S; Agarwala S; Jain V; Bakhshi S; Dhua A; Gulati S; Seth R; Srinivas M; Jana M; Kandasamy D; Bhatnagar V
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e924-e929. PubMed ID: 33769388
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and prognostic analysis of opsoclonus-myoclonus-ataxia syndrome in children].
Zhou J; Zhuo XW; Jin M; Duan C; Zhang WH; Ren CH; Gong S; Tian XJ; Ding CH; Ren XT; Li JW
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):256-261. PubMed ID: 38378288
[No Abstract] [Full Text] [Related]
8. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
Blaes F; Dharmalingam B
Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective.
Rossor T; Yeh EA; Khakoo Y; Angelini P; Hemingway C; Irani SR; Schleiermacher G; Santosh P; Lotze T; Dale RC; Deiva K; Hero B; Klein A; de Alarcon P; Gorman MP; Mitchell WG; Lim M;
Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35260471
[TBL] [Abstract][Full Text] [Related]
10. Five Years Follow-up of Opsoclonus-Myoclonus-Ataxia Syndrome-Associated Neurogenic Tumors in Children.
Aktekin EH; Gezer HÖ; Yazıcı N; Erol İ; Erbay A; Sarıalioğlu F
Neuropediatrics; 2024 Feb; 55(1):57-62. PubMed ID: 37019145
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome.
Panzer JA; Anand R; Dalmau J; Lynch DR
J Neuroimmunol; 2015 Sep; 286():86-92. PubMed ID: 26298330
[TBL] [Abstract][Full Text] [Related]
12. Role of BAFF in Opsoclonus-Myoclonus syndrome, a bridge between cancer and autoimmunity.
Raffaghello L; Fuhlhuber V; Bianchi G; Conte M; Blaes F; Gambini C; Pistoia V
J Leukoc Biol; 2013 Jul; 94(1):183-91. PubMed ID: 23610147
[TBL] [Abstract][Full Text] [Related]
13. Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome.
Berridge G; Menassa DA; Moloney T; Waters PJ; Welding I; Thomsen S; Zuberi S; Fischer R; Aricescu AR; Pike M; Dale RC; Kessler B; Vincent A; Lim M; Irani SR; Lang B
Neurology; 2018 Aug; 91(8):e714-e723. PubMed ID: 30045961
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic plasma exchange for a case of refractory opsoclonus myoclonus ataxia syndrome.
Greensher JE; Louie J; Fish JD
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28926689
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma presenting as opsoclonus-myoclonus: A series of six cases and review of literature.
Meena JP; Seth R; Chakrabarty B; Gulati S; Agrawala S; Naranje P
J Pediatr Neurosci; 2016; 11(4):373-377. PubMed ID: 28217170
[TBL] [Abstract][Full Text] [Related]
16. Opsoclonus-myoclonus-ataxia syndrome in children.
Bhatia P; Heim J; Cornejo P; Kane L; Santiago J; Kruer MC
J Neurol; 2022 Feb; 269(2):750-757. PubMed ID: 33779841
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastic Tumor Recurrence Associated With Opsoclonus Myoclonus Ataxia Syndrome Relapse a Decade After Initial Resection and Treatments.
Bacchus MK; Anderson DS; Berko ER; States LJ; Bagatell R; Hopkins SE; Batra V
J Pediatr Hematol Oncol; 2023 Apr; 45(3):152-154. PubMed ID: 36897628
[TBL] [Abstract][Full Text] [Related]
18. Opsoclonus myoclonus and ataxia syndrome with supraventricular tachycardia.
Garner S; Giakas A; Holder K; Galvan B; Edwards H
Proc (Bayl Univ Med Cent); 2023; 36(1):109-110. PubMed ID: 36578594
[TBL] [Abstract][Full Text] [Related]
19. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
Pediatr Blood Cancer; 2024 Apr; ():e31039. PubMed ID: 38689540
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma-associated Opsoclonous Myoclonous Ataxia Syndrome: Profile and Outcome Report on 15 Egyptian Patients.
Elzomor H; El Menawi S; Elawady H; Elkinaai N; Elshafie M; Refaat A; Ghareeb H; Fawzy M
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e194-e199. PubMed ID: 35462382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
